149 related articles for article (PubMed ID: 28314844)
1. Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression.
Jiang Y; Dai J; Yao Z; Shelley G; Keller ET
Mol Cancer Res; 2017 Jul; 15(7):875-883. PubMed ID: 28314844
[TBL] [Abstract][Full Text] [Related]
2. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
3. A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy.
Wirth M; Heidenreich A; Gschwend JE; Gil T; Zastrow S; Laniado M; Gerloff J; Zühlsdorf M; Mordenti G; Uhl W; Lannert H
Eur Urol; 2014 May; 65(5):897-904. PubMed ID: 23791392
[TBL] [Abstract][Full Text] [Related]
4. Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer.
Hussain M; Le Moulec S; Gimmi C; Bruns R; Straub J; Miller K;
Clin Cancer Res; 2016 Jul; 22(13):3192-200. PubMed ID: 26839144
[TBL] [Abstract][Full Text] [Related]
5. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
6. High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.
Wu YJ; Pagel MA; Muldoon LL; Fu R; Neuwelt EA
Anticancer Res; 2017 Aug; 37(8):4029-4040. PubMed ID: 28739685
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen.
Hayashido Y; Kitano H; Sakaue T; Fujii T; Suematsu M; Sakurai S; Okamoto T
Int J Oncol; 2014 Nov; 45(5):1875-82. PubMed ID: 25190218
[TBL] [Abstract][Full Text] [Related]
8. A Bispecific Antibody Targeting the αv and α5β1 Integrins Induces Integrin Degradation in Prostate Cancer Cells and Is Superior to Monospecific Antibodies.
Joshi R; Ren W; Mathew P
Mol Cancer Res; 2020 Jan; 18(1):27-32. PubMed ID: 31636091
[TBL] [Abstract][Full Text] [Related]
9. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
10. Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.
Wagner S; Rothweiler F; Anhorn MG; Sauer D; Riemann I; Weiss EC; Katsen-Globa A; Michaelis M; Cinatl J; Schwartz D; Kreuter J; von Briesen H; Langer K
Biomaterials; 2010 Mar; 31(8):2388-98. PubMed ID: 20031203
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv Integrins.
Gallo E; Kelil A; Haughey M; Cazares-Olivera M; Yates BP; Zhang M; Wang NY; Blazer L; Carderelli L; Adams JJ; Kossiakoff AA; Wells JA; Xie W; Sidhu SS
J Mol Biol; 2021 Jul; 433(15):167090. PubMed ID: 34090922
[TBL] [Abstract][Full Text] [Related]
12. The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.
Chen X; Corbin JM; Tipton GJ; Yang LV; Asch AS; Ruiz-Echevarría MJ
Biochim Biophys Acta; 2014 Jun; 1843(6):1216-24. PubMed ID: 24632071
[TBL] [Abstract][Full Text] [Related]
13. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
[TBL] [Abstract][Full Text] [Related]
14. Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion.
Duperret EK; Dahal A; Ridky TW
J Cell Sci; 2015 Nov; 128(21):3997-4013. PubMed ID: 26359297
[TBL] [Abstract][Full Text] [Related]
15. alphaV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma.
Koistinen P; Ahonen M; Kähäri VM; Heino J
Int J Cancer; 2004 Oct; 112(1):61-70. PubMed ID: 15305376
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide increases the migratory activity of non-small cell lung cancer cells via AKT-mediated integrin αv and β1 upregulation.
Saisongkorh V; Maiuthed A; Chanvorachote P
Cell Oncol (Dordr); 2016 Oct; 39(5):449-462. PubMed ID: 27376838
[TBL] [Abstract][Full Text] [Related]
17. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
[TBL] [Abstract][Full Text] [Related]
18. miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression.
Zoni E; van der Horst G; van de Merbel AF; Chen L; Rane JK; Pelger RC; Collins AT; Visakorpi T; Snaar-Jagalska BE; Maitland NJ; van der Pluijm G
Cancer Res; 2015 Jun; 75(11):2326-36. PubMed ID: 25858144
[TBL] [Abstract][Full Text] [Related]
19. Simulated physiological stretch increases expression of extracellular matrix proteins in human bladder smooth muscle cells via integrin α4/αv-FAK-ERK1/2 signaling pathway.
Chen S; Peng C; Wei X; Luo D; Lin Y; Yang T; Jin X; Gong L; Li H; Wang K
World J Urol; 2017 Aug; 35(8):1247-1254. PubMed ID: 28013345
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Integrin
Stojanović N; Dekanić A; Paradžik M; Majhen D; Ferenčak K; Ruščić J; Bardak I; Supina C; Tomicic MT; Christmann M; Osmak M; Ambriović-Ristov A
Mol Pharmacol; 2018 Dec; 94(6):1334-1351. PubMed ID: 30262596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
